Atlanta, GA – Curant Rare today announced a strategic collaboration with Cencora, a global pharmaceutical solutions organization, that aims to provide pharmaceutical companies developing rare disease therapies with an integrated solution to support the commercialization of their products. Rare disease therapies face unique challenges, including complex regulatory pathways and access barriers. This collaboration will leverage Cencora’s pharmaceutical logistics services and commercialization solutions, such as pharmacovigilance and market access support, and Curant Rare’s specialty pharmacy services and omnichannel patient engagement solutions. The integrated solution aims to streamline […]















